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Background: Many human and animal studies have shown the influence of nicotine and caffeine on pain
perception and processing. This study aims to investigate whether smoking or caffeine consumption influences
trigeminal pain processing.
Methods: Sixty healthy subjects were investigated using simultaneous recordings of the nociceptive blink reflex
(nBR) and pain related evoked potentials (PREP) following nociceptive electrical stimulation on both sides of the
forehead (V1). Thirty subjects were investigated before and after smoking a cigarette, as well as before and after
taking a tablet of 400 mg caffeine.
Results: After smoking PREP showed decreased N2 and P2 latencies indicating central facilitation at supraspinal
(thalamic or cortical) level. PREP amplitudes were not changed. NBR showed a decreased area under the curve
(AUC) indicating central inhibition at brainstem level. After caffeine intake no significant changes were observed
comparing nBR and PREP results before consumption.
Conclusions: Smoking influences trigeminal pain processing on supraspinal and brainstem level. In the investigated
setting, caffeine consumption does not significantly alter trigeminal pain processing. This observation might help in
the further understanding of the pathophysiology of pain disorders that are associated with excessive smoking
habits such as cluster headache. Previous smoking has to be taken into account when performing
electrophysiological studies to avoid bias of study results.
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The influence of caffeine and nicotine on pain process-
ing is well described in the literature. Various analgesic
as well as nociceptive properties of both substances were
reported, previously. Smoking and caffeine consumption
is quite common in the general population, and even
more pronounced in some patient populations (e.g.
smoking in cluster headache [1]. Caffeine itself can in-
duce or exacerbate some pain entities (e.g. migraine [2],
caffeine-withdrawal headache [3]). Furthermore, smokers
are more prone to develop back pain, and general
chronic pain conditions [4-14]. Additionally, higher pain
intensity scores were reported in smokers [15].
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in any medium, provided the original work is pspecifically remains unknown. Therefore, this study aims
to investigate the caffeine and nicotine related alter-
ations in trigeminal pain processing and its influence on
electrophysiological study results. To assess the trigemi-
nal nociceptive system, we used the nociceptive blink re-
flex (nBR) and trigeminal pain-related evoked potentials
(PREP). These non-invasive electrophysiological study
techniques allow nociception specific stimulation of the
trigeminal pain processing system [16] and are highly
sensitive for the detection of changes of trigeminal pro-
cessing [17] at brainstem (nBR) as well as supraspinal
(thalamic, cortical) level (PREP).Methods
Standard protocol approvals, registrations, and patients
consents
The study protocol was reviewed and approved by the Med-
ical Ethics Committee of the University of Duisburg-EssenOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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of Helsinki was obtained from all participants prior to
investigation.
Subjects
Sixty healthy subjects were investigated in a longitudinal
design. Thirty subjects were investigated before and 5 mi-
nutes after smoking a cigarette (mean age 27.2 ± 2.1 y;
range 24–32), 30 subjects were investigated before and
15 minutes after taking 400 mg caffeine orally (mean age
27.9 ± 3.3 y; range 24–39). The amount of 400 mg caffeine
equals approximately three cups of coffee. The subjects
were instructed not to smoke, consume caffeine-containing
beverages or eat within 4 hours prior to study participation.
Additional information on smoking habits and regular
coffee consumption were inquired. Eighteen subjects in the
smoking group smoked on a daily basis, 11 were social
smokers (<3 days with smoking a week), one subjects was
non-smoker. The mean caffeine consumption in the caf-
feine group was 157 mg ± 105 per day (range 0–400). Three
groups of caffeine consumption were defined: 1.) no or ir-
relevant caffeine consumption (<30 mg/d; 3 subjects); 2.)
moderate caffeine consumption (30–199 mg/d; 17 subjects);
3.) high caffeine consumption (>200 mg/d; 10 subjects).
Electrophysiological settings
Two planar concentric electrodes (Walter Graphtek
GmbH, Lübeck, Germany http://www.walter-graphtek.
com/) were attached to the skin 10 mm above the entry
zone of the supraorbital nerve. The outer rim of the first
electrode was placed 1 cm from the forehead midline, the
second electrode approximately 2 cm apart and lateral.
Left side and right side were stimulated 15 times per ses-
sion in each subject before and after smoking/caffeine
consumption (triple pulse, monopolar square wave, dur-
ation 0.5 ms, pulse interval 5 ms, interstimulus interval:
12 to 18 seconds, pseudo-randomized). Starting side of
stimulation was changed randomly. Perception and pain
thresholds were determined on the forehead with an as-
cending and descending sequence of 0.2 mA intensity
steps. The stimulus intensity was set at doubled individual
pain threshold. Initial stimulus intensity was retained in
the repletion after smoking or caffeine consumption.Table 1 Results of the nociceptive blink reflex before and aft
Groups Latency (ms) Latency (ms) Area under th
Before After
Coffeine 47.49 ± 6.15 47.64 ± 6.33 11
[36.65-63.40] [35.70-71.75] [24
Nicotine 46.00 ± 5.61 45.67 ± 4.39 11
[37.40-61.80] [35.20-54.50] [1
*p < 0.05 t-test paired samples
After smoking Area under the curve is significantly reduced in terms of an inhibitio
not influence results of the nociceptive blink reflex. Results are presented as meanStimuli were delivered to each side in pseudo random
order in terms of start site (i.e., left or right side of the
forehead).
NBR and PREP were recorded simultaneously follow-
ing trigeminal stimulation of the forehead. The nBR was
recorded using surface electrodes placed infraorbitally
referenced to the orbital rim. Recording parameters:
bandwidth 1 Hz to 1 kHz, sampling rate 2.5 kHz, sweep
length 300 ms (1401 plus, Signal, Cambridge Electronic
Design, UK). PREPs were recorded with electrodes placed
at Cz referenced to linked earlobes (A1-A2) according to
the international 10–20 system.
Signal analysis was performed by an investigator
blinded to the intervention (caffeine/smoking). The first
sweep was rejected to avoid contamination by startle re-
sponse. The remaining 14 sweeps were averaged. For
nBR onset latencies waveforms were rectified and ana-
lyzed for each sweep separately. A mean value for each
session was calculated. Areas under the curve were cal-
culated between 27 and 87 ms. Concerning PREP N2
(negative peak), P2 (positive peak) latencies and PPA
(peak-to-peak) amplitudes were analyzed.
Mean values of results after right and left side stimula-
tion and subsequent values for the group were calcu-
lated. Offline-analysis was performed with a custom-
written PC-based software using Matlab (Matlab 7, The
MathWorks, Natick, MA, USA).
Statistical analysis
As of the longitudinal design paired t-test was used to com-
pare mean values of AUC, nBR latency, PPA, N2 latency,
and P2 latency before and after smoking as well as before
and after caffeine consumption. Correlation between smok-
ing habits as well as caffeine intake was determined. All sta-
tistics were calculated with SPSS 16 (SPSS Inc., Chicago,
IL, USA). The level of significance was set to p < 0.05.
Results
Smoking








± standIn all subjects the R2 response could be identified.
Electrophysiological results of means aresuming caffeine 400 mg or smoking one cigarette
ve (x103) (ìV xms) Area under the curve (x103) (ìV xms)
re After
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responses are shown in Figure 1A. AUC was
significantly decreased after smoking (Z df 29;
p = 0.012), suggesting inhibition at brainstemre 1 Representative nBR and PREP curves before an after
king in a single subjects. NBR and PREP before smoking is
wn in black. NBR and PREP after smoking is shown in red.
Area under the curve is decreased after smoking a cigarette
gesting an inhibition of trigeminal pain processing at brainstem
l. (B) N2 and P2 latency are reduced after smoking a cigarette
gesting a facilitation of trigeminal pain processing at
raspinal level.level. Latency was unchanged before and after
smoking. No correlation between smoking
habits and electrophysiological results could
be determined.
 Pain related evoked potentials:
In 28 subjects PREP could be identified.
Electrophysiological results of means are summarized
in Table 2. Representative PREP responses are shown
in Figure 1B. N2 latency (p = 0.002) and P2 latency
(p = 0.022) were significantly reduced after smoking
suggesting a facilitation at supraspinal level.
Amplitudes were not significantly changed. No
correlation between smoking habits and
electrophysiological results could be determined.
Caffeine consumption
 Nociceptive blink reflex:
In 28 subjects the R2 response could be identified.
Electrophysiological results of means are
summarized in Table 1. No significant changes
regarding nBR latency and AUC were observed after
caffeine consumption. No correlation between
caffeine consumption and electrophysiological
results could be determined.
 Pain related evoked potentials:
In all subjects PREP could be identified.
Electrophysiological results of means are
summarized in Table 2. No significant changes
regarding N2 latency, P2 latency, and PPA were
observed after caffeine consumption. No correlation
of caffeine consumption and electrophysiological
results could be determined.
Discussion
Our results show inhibition at brainstem level and fa-
cilitation at supraspinal level of trigeminal pain pro-
cessing after smoking a cigarette in healthy volunteers.
After caffeine consumption no significant alterations
were observed.
The effect of nicotine on event related potentials was
investigated in several studies. In human pain models
the effects of nicotine are often inconsistent and some-
times even conflicting. In cold pressor tests pain thresh-
olds were increased by nicotine, whereas studies using
heat or electrical stimulation pain models reported
inconsistent or conflicting results [18]. Most of these
studies showed a nicotine driven facilitation of brain
processing in line with our findings [19-22]. In contrast
to our results, Miyazaki et al. showed nicotine-related
decreased amplitudes of laser evoked potentials [23].
The authors concluded that these alterations might re-
flect nicotine depended antinociceptive effects. However,
a correlation of electrophysiological inhibition and
Table 2 Results of the pain-related evoked potentials before and after consuming caffeine 400 mg or smoking a
cigarette
Groups N2 N2 P2 P2 PPA PPA
Before After Before After Before After
Coffeine 182.60 ± 12.49 182.43 ± 11.24 131.78 ± 10.39 131.78 ± 9.60 52.03 ± 20.46 48.48 ± 22.64
[165.90-211.70] [161.35-206.70] [108.90-52.80] [115.00-153.00] [19.70-128.30] [16.45-144.70
Nicotine 182.15 ± 12.49 176.89 ± 10.36*** 131.35 ± 9.35 128.32 ± 7.93* 51.55 ± 26.32 46.07 ± 22.63
[158.30-205.40] [161.30-199.10] [155.75-150.40] [113.00-141.70] [10.40-117.30] [13.70-84.45]
Results are presented as mean ± standard deviations and range.
*p < 0.05 t-test paired samples.
**p < 0.005 t-test paired samples.
After smoking N2 and P2 latency are significantly reduced showing a facilitation of trigeminal pain processing at supraspinal level.
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could not be established. One explanation for the variant
study results might be the different stimulation methods,
which are electric (i.e., direct skin nerve fiber depolarisa-
tion) and laser stimulation (i.e., indirect depolarisation of
nerve fibers by skin nociceptors).
Another reason for this inconsistency of the effect of
nicotine in humans might results from the fact that most
studies investigate smokers, who probably display various
kinds of habituation to the nicotinergic effects. Positron
emission tomography (PET) studies showed an increase of
AChRs (acetylcholine receptors) density compared to
non-smokers and ex-smokers [24]. Chronic exposure in-
duces widespread adaptive changes within the endogenous
opioid system, which leads to measurable effects that can
be subjectively reported by patients. For example, after
tooth extraction, smokers needed more analgesics than
non-smokers or light-smokers (<10 cigarettes a day) [25].
Pain sensitivity can be reduced by nicotine nasal spray or
transdermal patch. Additionally, the rapid wash-in and
wash-out period of nicotine after smoking as well as in-
take route (e.g. cigarettes, gum, intravenous, subcutane-
ous) and amount of nicotine absorption might make it
difficult to investigate subjects during the exact same
point of nicotine influence.
The observed alteration of trigeminal pain processing
at brain stem level might be based on inhibition of tri-
geminal subnucleus caudalis neuronal responses by nico-
tine. Animal experiments showed an initial increase
followed by a decline of firing rate of the trigeminal sub-
nucleus that even persisted after reapplication of nico-
tine suggesting a pattern of self-desensitization [26].
The complexity and inconsistency of nicotine effects
seems to offer an explanation for the observed parallel
inhibiton at brain stem level and the facilitation at
supraspinal level.
Unfortunately, our study can not differentiate whether
acute or chronic nicotine exposure might have different
impact on pain processing. It seems reasonable that
long term smokers may react different when smoking acigarette as further studies have to be performed to illu-
minate this interesting question. Additionally, more
studies are also needed to analyse whether and how pain
patients, for example cluster headache patients, show a
different smoking dependent trigeminal pain processing
compared with healthy controls.
Central effects of caffeine are well known and reported
in many studies. Its influence on pain processing is well
established. Caffeine is an antagonist of adenosine A1,
A2A and A2B receptors [27], which are localized at mul-
tiple sites such as the spinal cord, the thalamus and
other supraspinal sites [28]. Caffeine leads to augmenta-
tion of analgesic effects of several drugs such as
acetaminophen [29,30], and several non-steroidal anti-
inflammatory drugs (NSAIDs) Caffeine containing
mixed analgesics are widely used in several pain disor-
ders. However, in small doses caffeine-related hyperalge-
sia [31] and inhibition of analgesic effects of pain killers
(e.g. acetaminophen [31,32], amitriptyline [33-36], carba-
mazepine/oxcarbazepine [37,38], and venlafaxine [35])
were reported. The different properties were explained
by distinct receptor interaction. Although we did not
show any influence of caffeine on trigeminal pain pro-
cessing we cannot exclude any influence. Different dos-
ages as well as other application regimes might lead to a
divergent result. This might especially account for fre-
quent intake.
Some limitations of our study have to be addressed.
We did not measure nicotine or caffeine levels in the
blood and, therefore, we cannot correlate blood levels
with electrophysiological results. However, we chose
measuring times and dosages according to previously
conducted studies [23,39] and instructed patients to fas-
ten 4 h before study participation. However, a time inter-
val of 15 minutes after intake of caffeine might be too
short to detect the entire effect of this substance. Add-
itionally, we cannot exclude that different substances of
content others than nicotine might also influence our
study results. Furthermore, smoking is a more complex
activity that not only includes nicotine intake. Other
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on relaxation and reward systems might also be involved
in its mode of action that might effect electrophysio-
logical results.
One other major limitation is that we did not apply
any placebo intervention. However, as we recorded a
pattern of central facilitation and habituation only after
smoking a sole habituation effect based on re-testing
seems to be rather unlikely. Especially regarding smok-
ing a placebo intervention would be quite difficult to es-
tablish. Our study design tries to reflect the reality of
patients participating in electrophysiological studies as
lifelike as possible.
Conclusions
In summary, smoking displays direct impact on trigemi-
nal pain processing which can be detected by electro-
physiological investigations via nociceptive blink reflex
and pain related evoked potentials. The exact mecha-
nisms of this influence remain unknown, but might be
involved in the pathophysiology of pain disorders such
as cluster headache. Smoking should be considered a
confounding factor in future electrophysiological studies.
The period of time study participants should abstain
from smoking and the influence of nicotine habituation
in heavy and long-term smokers have to be investigated
in the future.
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